Immuron (IMRN) Debt Ratio (2016 - 2020)

Immuron (IMRN) recorded quarterly Debt Ratio of 0.01 in Q2 2020, up 322.22% quarter-over-quarter from 0.0 in Q2 2019, and up 322.22% on a YoY basis from 0.0 in Q3 2019.

Immuron (IMRN) Debt Ratio (2016 - 2020) Analysis & Trends

Immuron's Debt Ratio history runs 4 years deep, the most recent figure standing at 0.01 for Q2 2020.

  • In Q2 2020, Debt Ratio rose 322.22% year-over-year to 0.01; the TTM figure through Jun 2020 stood at 0.01 (up 322.22% YoY), while the FY2020 annual figure was 0.01, up 322.22% from the prior year.
  • Debt Ratio was 0.01 for Q2 2020 at Immuron, up from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.13 in Q4 2016 to a low of 0.0 in Q2 2019.
  • Historically, Debt Ratio has averaged 0.03 across 4 years, with a median of 0.03 in 2017.
  • The sharpest annual moves came in 2017 and 2020: Debt Ratio tumbled 78.66% in 2017, then surged 322.22% in 2020.
  • A 4-year view of Debt Ratio shows it stood at 0.13 in 2016, then sank by 78.66% to 0.03 in 2017, then slumped by 94.15% to 0.0 in 2019, then surged by 322.22% to 0.01 in 2020.
  • The last three Debt Ratio figures came in at 0.01 (Q2 2020), 0.0 (Q2 2019), and 0.03 (Q4 2017), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Immuron 921.61 Mn 921.58 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2020 0.01
Jun 30, 2019 0.00
Dec 31, 2017 0.03
Sep 28, 2017 0.03
Aug 31, 2017 0.03
Jun 30, 2017 0.02
Dec 31, 2016 0.13